ASPET is pleased to present Focus on Pharmacology – a new virtual series presenting high quality, innovative science in pharmacology and experimental therapeutics.
Join us for the first session on Thursday, July 30, 2020, 1:00 pm – 2:30 pm ET. This new series is free for ASPET members.
Coronavirus Series – Part 1: Antiviral Measures Targeting Coronavirus Entry
COVID-19 first began in late 2019 and as of July 2020 approximately 12 million people have been infected with a mortality rate of over 4% globally. The SARS-CoV-2 virus is differentiated from the many common coronavirus variants,
including those associated with the common cold, by its cross-species infectivity, rapid spread, and lethality. Rapid advances in the identification of this new coronavirus, and its putative host susceptibility factor, angiotensin converting
enzyme 2 (ACE2) as the SARS-CoV-2 cell surface receptor, have led to the proliferation of clinical drug repurposing and preclinical rational drug design efforts to combat this devastating pandemic.
Dr. Thomas Gallagher is a leading expert on the virology of coronaviruses. His talk will provide an overview of the virology of coronaviruses, the current understanding of SARS-CoV-2 viral entry and provide critical insights regarding various interventional
strategies to limit infectivity. Given the ongoing societal and economic impact of COVID-19 pandemic world-wide, this seminar will be of great interest to all ASPET members.
Michael F. Jarvis, PhD, FBPhS - AbbVie
Qing Ma, PharmD, PhD – University at Buffalo
Thomas Gallagher, PhD
Loyola University Chicago, Department of Microbiology and Immunology
Register for this session on ASPETConnect
Sign up today. Space is limited.
Learn more about the ASPET Focus on Pharmacology Virtual Series and view the schedule.
Not a member yet? Sign up now for your trial membership using
appeal code FOCUS20 to get the reduced trial membership rate. Your trial membership will run through December 31, 2020.